Clinic
Clhg-Ville Platte LLC
Clhg-Ville Platte LLC was paid $2.44M by Medicaid between May 2021 and Dec 2024, across 49 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
33Billing provider infoCLHG-VILLE PLATTE LLC
VILLE PLATTE, LA 70586
VILLE PLATTE, LA 70586
33aNPI1639720493assigned 09/24/2019
33bProvider typeRural Health Clinic/Center
28Total paid$2.44M
24GClaims71,736
24DCodes billed49
24AFirst – last monthMay 2021 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Louisiana
Rank by total paid#79 of 160
Median peer was paid$2.26M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 11,132 | $358K | |
| 2022 | 15,489 | $590K | |
| 2023 | 19,995 | $684K | |
| 2024incomplete | 25,120 | $808K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 22,630 | 16,612 | $2.44M |
| 71015 | <1% | 38 | 12 | $755.13 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 13,604 | 10,241 | $398.72 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,212 | 1,890 | $272.20 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,244 | 1,868 | $119.16 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,347 | 3,673 | $29.40 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,191 | 882 | $13.13 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,372 | 2,002 | $0.02 |
| 90648 | 0% | 1,625 | 1,408 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 0% | 524 | 431 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 3,144 | 2,673 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 589 | 233 | $0.00 |
37 more codes
| 90633 | 0% | 302 | $0.00 | |
| 90670 | 0% | 1,162 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 90671 | 0% | 458 | $0.00 | |
| 1159F | 0% | 562 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 215 | $0.00 |
| 3078F | 0% | 814 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 28 | $0.00 |
| 99173 | 0% | 909 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 50 | $0.00 |
| 1160F | 0% | 562 | $0.00 | |
| 90658 | 0% | 33 | $0.00 | |
| 83655 | 0% | 65 | $0.00 | |
| 3008F | 0% | 1,983 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 76 | $0.00 |
| 85018 | 0% | 133 | $0.00 | |
| 87807 | 0% | 302 | $0.00 | |
| 90680 | 0% | 792 | $0.00 | |
| 1126F | 0% | 140 | $0.00 | |
| 90723 | 0% | 1,042 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 2,693 | $0.00 |
| 90686 | 0% | 908 | $0.00 | |
| 92551 | 0% | 942 | $0.00 | |
| 1125F | 0% | 575 | $0.00 | |
| 90474 | 0% | 786 | $0.00 | |
| 1034F | 0% | 198 | $0.00 | |
| 1036F | 0% | 398 | $0.00 | |
| 99381 | 0% | 20 | $0.00 | |
| 3074F | 0% | 837 | $0.00 | |
| 20610 | 0% | 20 | $0.00 | |
| 90696 | 0% | 16 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 71 | $0.00 |
| 90716 | 0% | 29 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 18 | $0.00 |
| 90656 | 0% | 20 | $0.00 | |
| 00000 | 0% | 23 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGUILLARD, KRISTOPHER (CEO)
| Provider | Location | Paid |
|---|---|---|
| Clhg-Ville Platte LLC | Ville Platte, LA | $334K |
| Clhg-Ville Platte LLC | Ville Platte, LA | $68K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.